2009•Journal of Shanxi Datong UniversityRequires access

Clinical Study on the Effect of Valsartan combined with Metoprolol in Aged Chronic Heart Failure

Haixia Yu

Open publisher page 0 citations

Abstract

Objective To investigate the therapeutic effect of valsartan combined with metoprolol in gerontic patient with chronic heart failure(CHF).Methods 132 cases 60~77(68.5ys) of CHF Ⅱ、Ⅲ grade with NYHA heart function grade were divided into two group:valsartan and metoprolol combination group(n=66),and control group(n=66).All patients were followed up for 180days,including their heart function,LVEF by echocardiography,LVES,LVED,value in the treatment of chronic heart failure was also investigated.Results After 180 days,there were significant differences between combination group and control group in heart function grade,LVEF,LVES,LVED(P0.05 or P0.01).Conclusion Better clinical results are achieved by valsartan and metoprolol combination therapy in gerontic patients with chronic heart failure,Life quality of patients also improve by the combination therapy.

About this research paper

What this paper is about

Objective To investigate the therapeutic effect of valsartan combined with metoprolol in gerontic patient with chronic heart failure(CHF).Methods 132 cases 60~77(68.5ys) of CHF Ⅱ、Ⅲ grade with NYHA heart function grade were divided into two group:valsartan and metoprolol combination group(n=66),and control group(n=66).All patients were followed up for 180days,including their heart function,LVEF by echocardiography,LVES,LVED,value in the treatment of chronic heart failure was also investigated.Results After 180 days,there were significant differences between combination group and control group in heart function grade,LVEF,LVES,LVED(P0.05 or P0.01).Conclusion Better clinical results are achieved by valsartan and metoprolol combination therapy in gerontic patients with chronic heart failure,Life quality of patients also improve by the combination therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic effect of valsartan combined with metoprolol in gerontic patient with chronic heart failure(CHF).Methods 132 cases 60~77(68.5ys) of CHF Ⅱ、Ⅲ grade with NYHA heart function grade were divided into two group:valsartan and metoprolol combination group(n=66),and control group(n=66).All patients were followed up for 180days,including their heart function,LVEF by echocardiography,LVES,LVED,value in the treatment of chronic heart failure was also investigated.Results After 180 days,there were significant differences between combination group and control group in heart function grade,LVEF,LVES,LVED(P0.05 or P0.01).Conclusion Better clinical results are achieved by valsartan and metoprolol combination therapy in gerontic patients with chronic heart failure,Life quality of patients also improve by the combination therapy.

Key concepts: Metoprolol, Valsartan, Medicine, Heart failure, Ejection fraction, Internal medicine, Cardiology, Medical therapy

Related papers

Back to paper searchBrowse research topicsOriginal source
Clinical Study on the Effect of Valsartan combined with Metoprolol in Aged Chronic Heart Failure — Research Paper | ScholarLens